NYSE ARCA | ETF
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index.
The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business.
GLP-1 agonists seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss.
The fund is non-diversified.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 14.90% |
LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 12.52% |
NVO | Novo Nordisk A/S | Healthcare | Drug Manufacturers - General | 11.40% |
REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 6.97% |
4519 | Chugai Pharmaceutical Co. Ltd. | Healthcare | Drug Manufacturers - General | 6.89% |
AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 6.50% |
AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 5.90% |
MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 5.13% |
PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 5.11% |
ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 5.07% |
ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.04% |
GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 5.00% |
TEVA | Teva Pharma Industries Ltd ADR | Healthcare | Drug Manufacturers - Specialty & Generic | 4.96% |
AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 4.91% |
MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.79% |
WST | West Pharmaceutical Services Inc | Healthcare | Medical Instruments & Supplies | 4.65% |
4507 | Shionogi & Co. Ltd. | Healthcare | Drug Manufacturers - Specialty & Generic | 4.36% |
1801 | Innovent Biologics Inc | Healthcare | Biotechnology | 4.26% |
4901 | Fujifilm Holdings Corp. | Industrials | Conglomerates | 4.17% |
TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 3.82% |